KLBF - Managing production costs to maintain performance

KLBF - Managing production costs to maintain performance Kalbe Farma (KLBF) will continue to manage its production costs to maintain performance, this year. Moreover, KLBF will focus on: 1) its prescription drug segment by developing biological drugs, cell therapy, and vaccines, 2) healthcare products segment by developing wellness and preventive products, 3) nutritionals segment by developing products in liquid form, and 4) distribution and logistics segment by fostering new partnerships and developing medical devices. In order to achieve them, KLBF has allocated around IDR1 tn for this year' capex. Thus, KLBF expects its topline and bottom line to grow by 8-10% yoy, respectively this year. (Source : Kontan)